Skip to main content

DC/MM Fusion Vaccine

DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM

  • RegistryNCT07377435
  • PhasePhase 1
  • StatusRecruiting
  • ConditionMultiple Myeloma
  • SponsorDavid Avigan
How DC/MM Fusion Vaccine worksNCT073774351 min

What the film says

Read the transcript

This trial is for relapsed or refractory multiple myeloma, in adults eligible for standard BCMA CAR T cell therapy.

The idea: add a personalized cancer vaccine. The DC/MM fusion vaccine is an investigational agent that tries to help the immune system recognize and fight cancer cells. Patient cells are collected, and the vaccine is given with GM CSF, a growth factor, alongside the standard CAR T therapy.

This phase 1 study plans 25 patients and tracks safety first. At Beth Israel Deaconess Medical Center in Boston, Jacalyn Rosenblatt leads it.

Public record; not medical advice.

Sources behind this film

  • ClinicalTrials.gov record NCT07377435

    Relapsed or refractory multiple myeloma, adults eligible for standard BCMA CAR T therapy; DC/MM fusion vaccine is investigational and tries to help the immune system recognize and fight cancer cells; a personalized vaccine; Patient cells collected; vaccine given with GM CSF, a growth factor, alongside standard CAR T; Phase 1, 25 patients, safety first (+1 more lines)

The drug

What is being tested.

Dendritic Cell and tumor fusion vaccine, via subcutaneous injection (under the skin), per protocol.

Granulocyte-Macrophage Colony-Stimulating Factor, via subcutaneous injection, per standard of care.

This Phase I study is to evaluate the safety and effectiveness of dendritic cell DC/MM fusion vaccine in combination with standard of care B-cell maturation antigen (BCMA) CAR-T cell therapy in participants with relapsed/refractory multiple myeloma. The DC/MM fusion vaccine is an investigational agent that tries to help the immune system to recognize and fight against cancer cells. The U.S.

The study

How the trial runs.

This study is to evaluate the safety and effectiveness of dendritic cell DC/MM fusion vaccine in combination with standard of care B-cell maturation antigen (BCMA) CAR-T cell therapy in participants with relapsed/refractory multiple myeloma. The names of the study drugs involved in this study are: * DC/MM fusion vaccine (a type of personalized cancer vaccine) * Granulocyte-macrophage colony-stimulating factor (GM-CSF) (a type of growth factor or hormone)

Live record on ClinicalTrials.gov →

Eligibility

Who the study is looking for.

  • Patients must be eligible to receive standard of care CAR T-cell therapy for relapsed or refractory multiple myeloma
  • Patients must be ≥18 years of age
  • Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2
  • Patients must have 20% or more plasma cells in the bone marrow core or aspirate differential within 30 days prior to enrollment.
  • Total bilirubin ≤ 1.5 x institutional upper limit of normal

Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.

For you, or someone you love

Whether or not this trial is the one, bring AI into your corner.

A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.

Start your 7-day free trial

Then $9 a month. Cancel anytime.

  • Every record in one place

    Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.

  • Read in plain words

    Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.

  • Ready for every appointment

    Ask about your own file, and walk in with questions for your oncologist or the trial team.

  • Your people, in the loop

    Share one profile with the family helping you, and with your doctors.

Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.

How these trials work: what Phase 1 actually is · common questions Not clinical evidence.